BACE2 Antibodies

Santa Cruz Biotechnology features a diverse variety of BACE2 monoclonal antibodies for research focused on understanding BACE2 protein function. BACE2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).BACE2, or Beta-site APP Cleaving Enzyme 2, is a crucial enzyme involved in the processing of amyloid precursor protein (APP), which plays a significant role in Alzheimer's disease. By cleaving APP, BACE2 influences amyloid-beta peptide production, affecting neurodegenerative processes. Understanding BACE2 function is essential for developing therapeutic strategies aimed at mitigating the effects of Alzheimer's disease and other related disorders. Research utilizing BACE2 monoclonal antibodies has revealed important insights into APP processing pathways and potential therapeutic targets. Investigating BACE2 expression patterns helps identify its role in different tissues and cellular compartments. Studying BACE2 activity provides valuable information about its regulation and potential intervention points. Santa Cruz Biotechnology monoclonal antibodies for BACE2 support researchers worldwide in advancing our understanding of neurodegenerative diseases and developing new therapeutic approaches.